Skip to main content
OpenTrials

Clinical trial condition

Asthma

Explore clinical trials studying Asthma. Study availability and eligibility vary by location and protocol.

3,549 public trials 274 recruiting studies
Refine in advanced search Browse all conditions

Asthma trial results

Completed

Biomarkers of Cockroach Sublingual Immunotherapy 2

NCT01380327

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +12 more
Locations
  • Children's Memorial Hospital Chicago, Illinois, United States
  • Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
View Trial Details
Completed

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I

NCT01172808

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 205.418.01020 Boehringer Ingelheim Investigational Site Huntington Beach, California, United States
  • 205.418.01002 Boehringer Ingelheim Investigational Site Mission Viejo, California, United States
  • 205.418.01014 Boehringer Ingelheim Investigational Site San Diego, California, United States
  • 205.418.01011 Boehringer Ingelheim Investigational Site Wheat Ridge, Colorado, United States
View all 114 locations
View Trial Details
Completed

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II

NCT01172821

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 205.419.01058 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 205.419.01053 Boehringer Ingelheim Investigational Site Stockton, California, United States
  • 205.419.01061 Boehringer Ingelheim Investigational Site Centennial, Colorado, United States
  • 205.419.01066 Boehringer Ingelheim Investigational Site Denver, Colorado, United States
View all 125 locations
View Trial Details
Completed

Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma

NCT00317044

Conditions
Asthma, Bronchial Diseases, Deglutition Disorders, +13 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Fountain Valley, California, United States
View all 130 locations
View Trial Details
Completed

Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma

NCT00849095

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Ospedale regionale Umberto I, Unità Operativa di Allergologia Ancona, AN, Italy
  • Fondazione S. Maugeri - IRCCS -dipartimento di Pneumologia riabilitativa Cassano delle Murge, BA, Italy
  • Dipartimento di Scienze Mediche-Unità Operativa di Pneumologia Benevento, BN, Italy
  • Policlinico Sant'Orsola Malpighi, Unità Operativa di Pneumologia Bologna, BO, Italy
View all 31 locations
View Trial Details
Completed

Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma

NCT01122680

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 205.424.01002 Boehringer Ingelheim Investigational Site Denver, Colorado, United States
  • 205.424.01006 Boehringer Ingelheim Investigational Site Columbia, Missouri, United States
  • 205.424.01007 Boehringer Ingelheim Investigational Site Warrensburg, Missouri, United States
  • 205.424.01004 Boehringer Ingelheim Investigational Site Boys Town, Nebraska, United States
View all 19 locations
View Trial Details

Related conditions